Search Results - "Fleming GF"

Re: Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a.

Authors: Fleming GF Waggoner SE Wu S et al.

Source: JNCI: Journal of the National Cancer Institute. 01/15/97, Vol. 89 Issue 2, p172-173. 2p.

Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.

Authors: Farley JH Tian C Rose GS et al.

Source: Cancer (0008543X). 1/15/2010, Vol. 116 Issue 2, p355-361. 7p.

Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.

Authors: Ellis MJ Gao F Dehdashti F et al.

Source: JAMA: Journal of the American Medical Association. 8/19/2009, Vol. 302 Issue 7, p774-780. 7p.

Rare uterine cancers [corrected] [published erratum appears in LANCET ONCOL 2006 Feb;7(2):105].

Authors: Acharya S Hensley ML Montag AC et al.

Source: Lancet Oncology. Dec2005, Vol. 6 Issue 12, p961-971. 11p.

Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer.

Authors: Ly E Howard FM Chen N et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jun; Vol. 32 (4), pp. 641-647. Date of Electronic Publication: 2024 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer.

Authors: Lin K Michaels E Polley E et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jan; Vol. 32 (1), pp. 62-70. Date of Electronic Publication: 2024 Oct 13.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Authors: O'Regan RM Ren Y Zhang Y et al.

Source: JAMA network open [JAMA Netw Open] 2025 Nov 03; Vol. 8 (11), pp. e2540931. Date of Electronic Publication: 2025 Nov 03.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Authors: Francis PA Pagani O Fleming GF et al.

Corporate Authors: Francis PA Pagani O Fleming GF et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Jun 01. Date of Electronic Publication: 2026 Jun 01.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Identifying premenopausal patients with early-stage hormone receptor-positive breast cancer at minimal risk of distant recurrence by breast cancer index.

Authors: O'Regan RM Ren Y Zhang Y et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2026 Apr; Vol. 86, pp. 104714. Date of Electronic Publication: 2026 Jan 29.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Authors: Chen N Matossian M Saha P et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 May; Vol. 211 (1), pp. 111-119. Date of Electronic Publication: 2025 Feb 10.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Evaluation of a pharmacist-led medication review and optimisation service in the management of cardiometabolic disease.

Authors: Coleman P Keenan B Monaghan M et al.

Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2026 Mar 11. Date of Electronic Publication: 2026 Mar 11.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2047-9956 (Print) Linking ISSN: 20479956 NLM ISO Abbreviation: Eur J Hosp Pharm Subsets: MEDLINE

Ovarian cancer cell glucocorticoid receptor activation increases myeloid-derived suppressor cell tumor infiltration.

Authors: Taya M Gray E Srivastava T et al.

Source: Endocrinology [Endocrinology] 2026 Mar 06; Vol. 167 (4).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited Medium: Internet ISSN: 1945-7170 (Electronic) Linking ISSN: 00137227 NLM ISO Abbreviation: Endocrinology Subsets: MEDLINE

A Deeper Dive into POLE -Mutated Endometrial Carcinomas : The Contributions and Consequences of Tumor Mutational Burden.

Authors: Vemuri A Tjota MY Wanjari P et al.

Source: The American journal of surgical pathology [Am J Surg Pathol] 2026 Mar 01; Vol. 50 (3), pp. 301-312. Date of Electronic Publication: 2025 Dec 24.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am J Surg Pathol Subsets: MEDLINE

Successful treatment of gynecologic malignancy with trastuzumab deruxtecan in three patients with HER2 mutations.

Authors: Choudhury DS Kurnit KC Yamada SD et al.

Source: Gynecologic oncology reports [Gynecol Oncol Rep] 2025 Oct 13; Vol. 62, pp. 101974. Date of Electronic Publication: 2025 Oct 13 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE

Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center.

Authors: Ackroyd SA Sudilovsky G Che Y et al.

Source: Gynecologic oncology [Gynecol Oncol] 2025 Oct; Vol. 201, pp. 203-209. Date of Electronic Publication: 2025 Sep 04.

Publication Type: Journal Article

Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.

Authors: Ribi K Cole BF Fleming GF et al.

Source: Cancer [Cancer] 2025 Oct 01; Vol. 131 (19), pp. e70094.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer.

Authors: Stringer-Reasor EM Saha P Kocherginsky M et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Oct; Vol. 213 (3), pp. 347-354. Date of Electronic Publication: 2025 Aug 08.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Validation of the RSClin risk calculator in the National Cancer Data Base.

Authors: Vannier AGL Dhungana A Zhao F et al.

Source: Cancer [Cancer] 2024 Apr 15; Vol. 130 (8), pp. 1210-1220. Date of Electronic Publication: 2023 Dec 26.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Analysis of racial differences in HER2 status and molecular subtype in grade 3 endometroid endometrial carcinoma.

Authors: Ackroyd SA Sudilovsky G Che Y et al.

Source: Gynecologic oncology reports [Gynecol Oncol Rep] 2025 Aug 27; Vol. 61, pp. 101936. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE

Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results.

Authors: Coleman RL Fleming GF Brady MF et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115587. Date of Electronic Publication: 2025 Jun 17.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE